Transcranial Direct Current Stimulation and Cognitive Remediation Therapy for Psychosis
1 other identifier
interventional
33
1 country
1
Brief Summary
The proposed pilot study is a randomized controlled study to assess effectiveness of transcranial direct current stimulation (tDCS) to enhance cognitive remediation therapy in patients with psychotic disorders. tDCS. Patients will be randomized into two arms: active tDCS vs. sham tDCS. The active tDCS will be applied at a current of 1-2 mA (milliamperes) via two saline soaked electrode sponges (3 cm x 4.5 cm) applied to the side of the head. The investigators hypothesis is that the use of tDCS will enhance the improvement seen with cognitive remediation therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 6, 2014
CompletedFirst Posted
Study publicly available on registry
March 12, 2014
CompletedStudy Start
First participant enrolled
March 14, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 9, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 9, 2023
CompletedResults Posted
Study results publicly available
March 12, 2025
CompletedMarch 12, 2025
February 1, 2025
3.9 years
March 6, 2014
June 12, 2024
February 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in Brief Assessment of Cognition in Schizophrenia (BACS) From Baseline to Post-Training
Clinician-administered neurocognitive battery that assesses the aspects of cognition found to be most impaired and most strongly correlated with outcome in patients with schizophrenia. Brief Assessment of Cognition in Schizophrenia (BACS) - post training composite z-score range Arm 1 = -2.46 - 2.24 range Arm 2 = -7.67 - 0.83 Higher scores represent better cognitive performance. The BAC APP composite z-score is calculated as the sum of the subscale z-scores (i.e., verbal memory, digit sequencing, verbal fluency, symbol coding, and tower of london), adjusted by participant age and sex. The primary outcome measure from the BACS is a composite z score, with 0 representing the population mean, normed by age and gender.
Baseline, 3-5 weeks
Change in the Virtual Reality Functional Capacity Assessment Tool (VRFCAT) From Baseline to Post-Training
The VRFCAT is a performance-based functional capacity measure and the 'total recipes accessed' variable represents one component of the full measure. Using a realistic virtual reality environment, the VRFCAT assesses a subject's ability to complete instrumental activities associated with a shopping trip. This provides an estimate of performance on everyday functional tasks. The summary measures include: total time (seconds), total errors, total progressions, total bus schedule checks, total recipe checks. There is no combined total score for this Tool. The minimum number of recipe checks is 0 and there is no maximum number of recipe checks for this task. A higher score on the summary measure 'total recipe checks' indicates worse performance. This means that the higher the number of times a subject consults the reference materials (i.e., recipe), the worse the performance. Based o
Baseline, 3-5 weeks
Change in the D-prime Score of the N-Back Working Memory Test From Baseline to Post-Training
N-back testing is a performance task used to assess working memory. In this task, pairs of numbers are presented on a computer screen, and participant are instructed to press a button whenever the pair of numbers corresponds to the pair of numbers presented two trials before (2-back). Number of hits and number of false alarms are used to calculate d-prime, the primary outcome. Depending on the number of trials completed, the range of d-prime is expected to be from -4.46 (0 hits, 80 FA) to +4.46 (20 hits, 0 FA), based on the literature. In our study, hits ranged from 3-56 and false alarms ranged from 1-146, therefore d-prime ranged from -0.42-4.02 in the full sample for the 2-back condition. A lower score on d-prime indicates worse performance.
Baseline, 3-5 weeks
Secondary Outcomes (2)
N-Back - Post Training 2-back Number of Hits Provided Here
3-5 weeks
N-Back - Post Training 2-back Number of False Alarms Provided Here
3-5weeks
Study Arms (2)
Active tDCS
ACTIVE COMPARATORThe active tDCS will be applied at a current of 1-2mA via two saline soaked electrode sponges (3 cm x 4.5 cm) for the first 20 minutes of each CRT session in the active condition.
Sham tDCS
SHAM COMPARATORIn the sham condition, tDCS will be ramped up to 1-2 mA via two saline soaked electrode sponges (3 cm x 4.5 cm) over the first 30 seconds of each CRT session and then turned off.
Interventions
Transcranial direct current stimulation (tDCS) is a form of non-invasive neuromodulation that has been shown to enhance learning. tDCS is applied with current intensity of 1-2 mA of direct current and can be applied both before and during each cognitive remediation treatment session. Two saline soaked electrode sponges will be applied to the scalp.
Eligibility Criteria
You may qualify if:
- Meet diagnostic criteria for schizophrenia or schizoaffective disorder
- Are age 18-64
- Fluent in written and spoken English
- Have an outpatient status of at least 1 month prior to participation
- Has been on a stable dose of psychiatric medication for at least one month prior to participation
You may not qualify if:
- History of seizures or epilepsy
- Metallic cranial plates, screws, or implanted devices
- History of craniotomy
- History of stroke
- History of eczema on scalp
- Pre-existing sores or lesions at sites of tDCS electrode placement
- Non removable facial piercings
- Current or possibility of current pregnancy
- Has received a clinically meaningful dose of a targeted cognitive training intervention in the last 12 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Minnesota
Minneapolis, Minnesota, 55454, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Caroline Demro
- Organization
- University of Minnesota
Study Officials
- PRINCIPAL INVESTIGATOR
Ian S Ramsay, PhD
University of Minnesota
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 6, 2014
First Posted
March 12, 2014
Study Start
March 14, 2019
Primary Completion
February 9, 2023
Study Completion
February 9, 2023
Last Updated
March 12, 2025
Results First Posted
March 12, 2025
Record last verified: 2025-02